- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00073424
Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents
Cognitive, Behavioral, and Psychosocial Correlates of Medication Adherence in Children and Adolescents With HIV-1 Infection
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Medication adherence is a critical issue for HIV infected children and adolescents because of drug resistance and the increased complexity of treatment regimens. Children and adolescents with HIV face depression, anxiety, denial, and rebellion that may interfere with their motivation to take medication. Depression and self-perceived social support have been found to predict regimen adherence in adults with HIV. Children with other chronic diseases are less likely to adhere to their medication regimens if they also have behavioral or emotional problems; assessing emotional and behavioral function in children and adolescents with HIV may help in predicting adherence and explaining adherence failure. This study will correlate cognitive, behavioral, and psychosocial functioning with measures of virologic suppression and immunological status, and it will compare self-report and pill count measures of adherence in a randomly selected subset of perinatally infected HIV participants of PACTG 219C.
Children and adolescents currently enrolled in PACTG 219C will be randomly selected for this study, which will last for 48 weeks. At entry, participants will undergo neuropsychological evaluation, including academic achievement, attention, memory, language comprehension, and behavior assessments, and complete a health beliefs questionnaire. Both the participants and their parents or primary caregivers will complete questionnaires at study entry and Weeks 24 and 48. Adherence will be evaluated from self-reported and pill count measures (Weeks 4 and 24) and the PACTG 219C Adherence Module (Weeks 24 and 48).
Tipo de estudio
Inscripción
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233
- UAB, Dept. of Ped., Div. of Infectious Diseases
-
-
Arizona
-
Phoenix, Arizona, Estados Unidos, 85006
- Phoenix Children's Hosp.
-
-
California
-
Long Beach, California, Estados Unidos, 90801
- Long Beach Memorial Med. Ctr., Miller Children's Hosp.
-
Los Angeles, California, Estados Unidos, 90033
- Usc La Nichd Crs
-
Oakland, California, Estados Unidos, 94609-1809
- Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.
-
San Diego, California, Estados Unidos, 92103
- UCSD Mother-Child-Adolescent Program CRS
-
San Francisco, California, Estados Unidos, 94143-0105
- UCSF Pediatric AIDS CRS
-
-
Colorado
-
Denver, Colorado, Estados Unidos, 80218-1088
- Univ. of Colorado Denver NICHD CRS
-
-
Connecticut
-
New Haven, Connecticut, Estados Unidos, 06504
- Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease
-
-
District of Columbia
-
Washington, District of Columbia, Estados Unidos, 20010
- Children's National Med. Ctr., ACTU
-
Washington, District of Columbia, Estados Unidos, 20060
- Howard Univ. Washington DC NICHD CRS
-
-
Florida
-
Fort Lauderdale, Florida, Estados Unidos, 33316
- South Florida CDTC Ft Lauderdale NICHD CRS
-
Miami, Florida, Estados Unidos, 33136
- Univ. of Miami Ped. Perinatal HIV/AIDS CRS
-
-
Georgia
-
Augusta, Georgia, Estados Unidos, 30912
- Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60614
- Chicago Children's CRS
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70112-2699
- Tulane/LSU Maternal/Child CRS
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology
-
Baltimore, Maryland, Estados Unidos
- Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02115
- HMS - Children's Hosp. Boston, Div. of Infectious Diseases
-
Springfield, Massachusetts, Estados Unidos, 01199
- Baystate Medical Center, Springfield
-
-
New Jersey
-
Newark, New Jersey, Estados Unidos, 07101-1709
- NJ Med. School CRS
-
-
New York
-
Bronx, New York, Estados Unidos, 10457
- Bronx-Lebanon Hosp. IMPAACT CRS
-
Bronx, New York, Estados Unidos, 10461
- Jacobi Med. Ctr.
-
Brooklyn, New York, Estados Unidos, 11203-2098
- SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS
-
New York, New York, Estados Unidos, 10016
- Nyu Ny Nichd Crs
-
New York, New York, Estados Unidos, 10037
- Harlem Hosp. Ctr. NY NICHD CRS
-
Stony Brook, New York, Estados Unidos, 11794-8111
- SUNY Stony Brook NICHD CRS
-
Syracuse, New York, Estados Unidos, 13210
- SUNY Upstate Med. Univ., Dept. of Peds.
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27599-7220
- UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases
-
Durham, North Carolina, Estados Unidos, 27705
- DUMC Ped. CRS
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19134
- St. Christopher's Hosp. for Children
-
Philadelphia, Pennsylvania, Estados Unidos, 19104-4318
- The Children's Hosp. of Philadelphia IMPAACT CRS
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38105-2794
- St. Jude/UTHSC CRS
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Texas Children's Hosp. CRS
-
-
-
-
-
San Juan, Puerto Rico
- San Juan City Hosp. PR NICHD CRS
-
San Juan, Puerto Rico, 00936-5067
- Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria
- HIV-1 perinatal infection
- Already enrolled and in active follow-up in PACTG 219C
- Can communicate in English or Spanish
- On antiretroviral medication regimen at the time of enrollment, regardless of compliance with regimen, with no planned treatment interruptions
Exclusion Criteria
- Acquired HIV via routes other than perinatal transmission or source of HIV infection is unknown
- HIV-2 infection
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Colaboradores e Investigadores
Colaboradores
Investigadores
- Silla de estudio: Sharon Nichols, PhD, Department of Neurosciences, University of California, San Diego
Publicaciones y enlaces útiles
Publicaciones Generales
- Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000 Mar;19(2):124-33.
- Gaughan DM, Hughes MD, Oleske JM, Malee K, Gore CA, Nachman S; Pediatric AIDS Clinical Trials Group 219C Team. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics. 2004 Jun;113(6):e544-51. doi: 10.1542/peds.113.6.e544.
- Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999 Sep 10;13(13):1763-9. doi: 10.1097/00002030-199909100-00021.
- Rogers AS, Miller S, Murphy DA, Tanney M, Fortune T. The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. J Adolesc Health. 2001 Sep;29(3 Suppl):30-8. doi: 10.1016/s1054-139x(01)00289-0. No abstract available.
- Farley JJ, Montepiedra G, Storm D, Sirois PA, Malee K, Garvie P, Kammerer B, Naar-King S, Nichols S; PACTG P1042S Team. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count. J Dev Behav Pediatr. 2008 Oct;29(5):377-84. doi: 10.1097/DBP.0b013e3181856d22.
- Naar-King S, Montepiedra G, Nichols S, Farley J, Garvie PA, Kammerer B, Malee K, Sirois PA, Storm D; PACTG P1042S Team. Allocation of family responsibility for illness management in pediatric HIV. J Pediatr Psychol. 2009 Mar;34(2):187-94. doi: 10.1093/jpepsy/jsn065. Epub 2008 Jun 27.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- PACTG P1042s
- 10107 (Otro identificador: CTEP)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .